TrademarkDir
SELEPEN
DEAD

Serial Number

73411552

Owner

LYPHOMED, INC.

First Use Date

Jan 12, 1982

Filing Date

Jan 31, 1983

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SELEPEN Trademark

Serial Number: 73411552 • Registration: 1282073

SELEPEN is a trademark filed by LYPHOMED, INC. on January 31, 1983. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

LYPHOMED, INC. (29 trademarks)

MELROSE PARK, IL 60160

Entity Type: 03

Trademark Details

Filing Date

January 31, 1983

Registration Date

June 19, 1984

First Use Anywhere

January 12, 1982

First Use in Commerce

January 12, 1982

Published for Opposition

March 27, 1984

Cancellation Date

March 26, 2005

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Mar 26, 2005 CAEX
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Mar 26, 2005 CAEX
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 27, 1989 C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 27, 1989 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Sep 20, 1989 815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Sep 20, 1989 815F
REGISTERED-PRINCIPAL REGISTER
Jun 19, 1984 R.PR
REGISTERED-PRINCIPAL REGISTER
Jun 19, 1984 R.PR
PUBLISHED FOR OPPOSITION
Mar 27, 1984 PUBO
PUBLISHED FOR OPPOSITION
Mar 27, 1984 PUBO
NOTICE OF PUBLICATION
Feb 10, 1984 NPUB
NOTICE OF PUBLICATION
Feb 10, 1984 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 1983 CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 1983 CNSA
ASSIGNED TO EXAMINER
Dec 8, 1983 DOCK
ASSIGNED TO EXAMINER
Dec 8, 1983 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 1983 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 1983 CRFA
NON-FINAL ACTION MAILED
Oct 3, 1983 CNRT
NON-FINAL ACTION MAILED
Oct 3, 1983 CNRT
ASSIGNED TO EXAMINER
Sep 23, 1983 DOCK
ASSIGNED TO EXAMINER
Sep 23, 1983 DOCK

Related Trademarks

More from this Owner

LYPHOCIN

LYPHOCIN

LYPHOCIN

LYPHOCIN

LYPHOCIN

LYPHOCIN

IPHARM

IPHARM

IPHARM

IPHARM

IPHARM

IPHARM